Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

New Findings | 16 Nov 2012

Enzyme, Exposed

MALT1 emerges as a potentially druggable target for MS

Stephani Sutherland
In experimental autoimmune encephalomyelitis, and perhaps in multiple sclerosis, too, T helper 17 cells...
Laboratory Research
Olfactory system
New Findings | 10 Jun 2014

Sniffing Out Demyelination

Researchers have found evidence of demyelination and axonal loss in olfactory tissue. Could the olfactory system be an important link between environmental exposures and MS?

Carol Cruzan Morton
Whether it’s an aromatic meal, fragrant flowers, or a gas leak—some people with multiple sclerosis have...
Clinical Research
Figure 3
New Findings | 15 Dec 2014

Azathioprine: Old Drug, New Data

Azathioprine may be as effective as interferon β in relapsing-remitting multiple sclerosis, a noninferiority trial suggests

Carol Cruzan Morton
Call it That ’80s Drug. Azathioprine (Immuran and others), a generic immunosuppressant, has been used...
Clinical Research, Drug Development, Methods
Podcasts | 20 Aug 2015

Episode 51 with Dr. Luke Lairson on discovery of small molecules to induce remyelination

MSDF interviews Luke Lairson PhD of The Scripps Research Institute and the California Institute for Biomedical Research about a drug screen to find potential remyelination compounds and the strategy for researching their potential usefulness as candidate drugs to repair tissue damage in MS.

MS Discovery
Links to articles and other resources mentioned in Episode 51
Drug Development, Laboratory Research, Methods
Research Roundup logo
News Briefs | 29 Jan 2014

MS Research Roundup: January 29, 2014

B Cells for MS Diagnosis; More Research Needed on Laquinimod for European Regulators; Update on Toxin Trigger; New Way to Distribute Public Research Funds

Carol Cruzan Morton
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People
THC
News Briefs | 14 May 2014

AAN Review Supports Treating Symptoms of MS with Cannabis

A review of the literature conducted by the American Academy of Neurology supports the use of cannabis to treat some symptoms of MS, including spasticity, pain related to spasticity, overactive bladder, and painful burning and numbness

Lisa J. Bain
A review of available scientific research presented at the AAN Annual Meeting found that certain forms of cannabis can...
Clinical Research

Pages